Close Menu

NEW YORK (GenomeWeb) – Software firm Syapse said today that it raised $10 million in a Series B financing round led by Safeguard Scientifics with participation from Series A investor The Social+Capital Partnership.

Syapse said that it will use the funds to expand its sales, marketing, and client services, as well as further accelerate product development. The funds will also support the firm's efforts to provide its Precision Medicine Data platform to healthcare providers, enabling them to use genomics and clinical data in their treatment decisions.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.

Dec
15
Sponsored by
UgenTec

Diverse components of the UC Davis campus have been mobilized to deploy HTP testing to provide a safe working environment and keep the pandemic under control.